This early-stage study tests different doses of an experimental oral drug called TRX-100 in people with mild to moderate influenza. About 105 participants will receive the study drug plus standard flu care. The main goals are to check safety and find the best dose, while also tra…
Phase: PHASE2 • Sponsor: Traws Pharma, Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC